OptimizeRx appoints Microsoft Health COO Mary Varghese Presti to board

OptimizeRx Corp

Mary Varghese Presti appointed independent director effective April 3, 2026; board expanded to 7 members.
She serves on Audit Committee; receives $45k annual cash retainer plus $175k equity grant and $10k audit fee.
Varghese Presti is Microsoft Corporate VP & COO, Health & Life Sciences, with 25+ years in healthcare/tech.
CEO cites her experience in M&A, platform scaling, and commercialization as aligning with OptimizeRx strategy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.